Joachim Greilberger

7PUBLICATIONS
3CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 16, 2025
5-Hydroxymethylfurfural: A Particularly Harmful Molecule Inducing Toxic Lipids and Proteins?

Joachim Greilberger, Georg Feigl, Matthias Greilberger

|Jun 19, 2024
The Influence of N-Acetyl-selenomethionine on Two RONS-Generating Cancer Cell Lines Compared to N-Acetyl-methionine.

Joachim Greilberger, Philipp Stiegler, Michaela Greilberger

|Aug 25, 2023
Different RONS Generation in MTC-SK and NSCL Cells Lead to Varying Antitumoral Effects of Alpha-Ketoglutarate + 5-HMF.

Joachim Greilberger, Katharina Erlbacher, Philipp Stiegler

|Aug 26, 2022
Alpha-Ketoglutarate or 5-HMF: Single Compounds Effectively Eliminate Leukemia Cells via Caspase-3 Apoptosis and Antioxidative Pathways.

Joachim Greilberger, Ralf Herwig, Mehtap Kacar

|Jul 27, 2022
Vitamin D-Dimer: A Possible Biomolecule Modulator in Cytotoxic and Phagocytosis Processes?

Ralf Herwig, Katharina Erlbacher, Amela Ibrahimagic

|Nov 27, 2021
Alpha-Ketoglutarate and 5-HMF: A Potential Anti-Tumoral Combination against Leukemia Cells.

Joachim Greilberger, Ralf Herwig, Michaela Greilberger

Pageof 2